Depressive Disorder. Depressive episode
Conditions
Interventions
Intervention 1: control: placebo, tablet 1mg in bed time, for two weeks. Intervention 2: Intervention: Trazosin, Tablet 1m in bed time, for two weeks.
Placebo
Treatment - Drugs
control: placebo, tablet 1mg in bed time, for two weeks
Intervention: Trazosin, Tablet 1m in bed time, for two weeks
Sponsors
Deputy Dean of Research, Hamadan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: The patients who referred to the psychology clinic of Farshchian Hospital or to the private clinic of the psychologists of Hamadan city and were depressed based on the DSM IV-TR criteria, had sweating side effect due to the consumption of Sertralin Exclusion criteria: not willing to participate in each stage of the experiment, presence of systemic disease such as hypertension, diabetes, presence of other psychological disorder, using other medicine or suffering from the side effect of Trazosin or placebo like orthostatic hypotension, vertigo, headache
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sweating. Timepoint: Baseline and 2 weeks after the intervention. Method of measurement: visual analog scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Headache. Timepoint: daily. Method of measurement: case talking.;Sexual insufficiency. Timepoint: daily. Method of measurement: physical axam and case talking.;Orthostatic hypotension. Timepoint: Daily. Method of measurement: physical axam and case talking.;Palpitation. Timepoint: daily. Method of measurement: physical axam and case talking.;Vertigo. Timepoint: Daily. Method of measurement: physical axam and case talking.;Nasal cogestion. Timepoint: Daily. Method of measurement: physical axam and case talking. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAli Ghaleiha
Deputy Dean of Research, Hamadan University of Medical Sciences
Outcome results
None listed